$364 Million is the total value of Endurant Capital Management LP's 57 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 78.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | INVACARE CORPnote 5.000%11/1 | $36,638,000 | +89.7% | 37,566,000 | +88.1% | 10.07% | +100.0% | |
| LH | Buy | LABORATORY CORP AMER HLDGS | $17,356,000 | +50.5% | 62,919 | +39.1% | 4.77% | +58.6% |
| CI | New | CIGNA CORP NEW | $17,035,000 | – | 71,856 | +100.0% | 4.68% | – |
| ICLR | New | ICON PLC | $16,416,000 | – | 79,415 | +100.0% | 4.51% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $14,972,000 | – | 29,679 | +100.0% | 4.12% | – |
| THC | New | TENET HEALTHCARE CORP | $14,597,000 | – | 217,891 | +100.0% | 4.01% | – |
| RCM | Buy | R1 RCM INC | $12,207,000 | +356.8% | 548,876 | +407.1% | 3.36% | +381.3% |
| SYNH | Buy | SYNEOS HEALTH INCcl a | $11,655,000 | +45.6% | 130,238 | +23.4% | 3.20% | +53.5% |
| IVC | Buy | INVACARE CORP | $11,095,000 | +25.0% | 1,374,840 | +24.2% | 3.05% | +31.7% |
| ABBV | Sell | ABBVIE INC | $9,632,000 | +1.2% | 85,514 | -2.8% | 2.65% | +6.6% |
| AZYO | Buy | AZIYO BIOLOGICS INC | $8,391,000 | +4.0% | 873,159 | +49.6% | 2.31% | +9.7% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $8,096,000 | +12.4% | 570,970 | +30.1% | 2.22% | +18.5% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $7,923,000 | +5.8% | 2,129,709 | -1.6% | 2.18% | +11.6% |
| HAE | Buy | HAEMONETICS CORP MASS | $7,857,000 | +367.4% | 117,904 | +678.8% | 2.16% | +392.9% |
| EAR | New | EARGO INC | $7,721,000 | – | 193,471 | +100.0% | 2.12% | – |
| BIO | Sell | BIO RAD LABS INCcl a | $7,616,000 | -9.8% | 11,820 | -20.0% | 2.09% | -5.0% |
| INSM | Buy | INSMED INC | $7,409,000 | +64.3% | 260,314 | +96.6% | 2.04% | +73.1% |
| HOLX | New | HOLOGIC INC | $7,395,000 | – | 110,840 | +100.0% | 2.03% | – |
| HUM | New | HUMANA INC | $6,991,000 | – | 15,791 | +100.0% | 1.92% | – |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $6,754,000 | -54.3% | 101,081 | -56.8% | 1.86% | -51.8% |
| XRAY | New | DENTSPLY SIRONA INC | $6,570,000 | – | 103,860 | +100.0% | 1.81% | – |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,558,000 | +34.9% | 1,539,435 | +68.1% | 1.80% | +42.1% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $5,849,000 | -34.7% | 748,013 | +5.4% | 1.61% | -31.1% |
| Buy | TRILLIUM THERAPEUTICS INC | $5,828,000 | +13.4% | 600,788 | +25.6% | 1.60% | +19.6% | |
| VCYT | New | VERACYTE INC | $5,606,000 | – | 140,211 | +100.0% | 1.54% | – |
| New | INSMED INCnote 0.750% 6/0 | $5,539,000 | – | 5,000,000 | +100.0% | 1.52% | – | |
| Sell | DARIOHEALTH CORP | $5,527,000 | -9.7% | 258,774 | -18.6% | 1.52% | -4.8% | |
| JNJ | Buy | JOHNSON & JOHNSON | $5,436,000 | +14.6% | 32,998 | +14.4% | 1.49% | +20.9% |
| AVTR | Sell | AVANTOR INC | $5,412,000 | -22.4% | 152,395 | -36.8% | 1.49% | -18.2% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $4,778,000 | -35.5% | 41,729 | -33.5% | 1.31% | -32.0% |
| ANTM | Sell | ANTHEM INC | $4,559,000 | -60.1% | 11,941 | -62.4% | 1.25% | -57.9% |
| FATE | Buy | FATE THERAPEUTICS INC | $4,429,000 | +300.1% | 51,031 | +279.9% | 1.22% | +321.1% |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $4,298,000 | – | 139,124 | +100.0% | 1.18% | – |
| CALT | Buy | CALLIDITAS THERAPEUTICS ABsponsered ads | $4,252,000 | +8.4% | 144,393 | +1.5% | 1.17% | +14.3% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $4,173,000 | -57.6% | 160,362 | -48.4% | 1.15% | -55.3% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $3,875,000 | -6.1% | 926,935 | +1.7% | 1.06% | -1.0% |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $3,648,000 | – | 199,565 | +100.0% | 1.00% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $3,642,000 | +0.1% | 103,512 | +0.3% | 1.00% | +5.6% |
| MDVL | Buy | MEDAVAIL HOLDINGS INC | $3,579,000 | +11.3% | 292,196 | +27.2% | 0.98% | +17.3% |
| REGN | New | REGENERON PHARMACEUTICALS | $3,107,000 | – | 5,563 | +100.0% | 0.85% | – |
| TFX | New | TELEFLEX INCORPORATED | $3,014,000 | – | 7,501 | +100.0% | 0.83% | – |
| OMI | Buy | OWENS & MINOR INC NEW | $2,836,000 | +17.9% | 66,989 | +4.7% | 0.78% | +24.2% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $2,399,000 | -46.9% | 756,915 | -43.5% | 0.66% | -44.0% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $2,225,000 | – | 28,625 | +100.0% | 0.61% | – |
| IMUX | Buy | IMMUNIC INC | $2,172,000 | +3.4% | 177,148 | +34.4% | 0.60% | +8.9% |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $2,120,000 | -42.8% | 2,607,674 | +9.7% | 0.58% | -39.7% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,096,000 | -81.7% | 119,378 | -73.8% | 0.58% | -80.7% |
| BAX | New | BAXTER INTL INC | $2,017,000 | – | 25,059 | +100.0% | 0.55% | – |
| PNTG | New | PENNANT GROUP INC | $1,942,000 | – | 47,475 | +100.0% | 0.53% | – |
| FBRX | Buy | FORTE BIOSCIENCES INC | $1,794,000 | +89.6% | 53,369 | +93.4% | 0.49% | +99.6% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $1,523,000 | – | 7,553 | +100.0% | 0.42% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $1,264,000 | +4.9% | 406,537 | +29.5% | 0.35% | +10.5% |
| SIBN | New | SI-BONE INC | $1,264,000 | – | 40,155 | +100.0% | 0.35% | – |
| CYAD | New | CELYAD ONCOLOGY SAadr | $845,000 | – | 160,691 | +100.0% | 0.23% | – |
| CANO | New | CANO HEALTH INC | $750,000 | – | 62,013 | +100.0% | 0.21% | – |
| PRVB | New | PROVENTION BIO INC | $699,000 | – | 82,960 | +100.0% | 0.19% | – |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $461,000 | -64.8% | 70,969 | -53.3% | 0.13% | -62.8% |
| LBPH | Exit | LONGBOARD PHARMACEUTICALS IN | $0 | – | -16,327 | -100.0% | -0.07% | – |
| TARS | Exit | TARSUS PHARMACEUTICALS INC | $0 | – | -14,143 | -100.0% | -0.12% | – |
| BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -17,777 | -100.0% | -0.15% | – |
| STRM | Exit | STREAMLINE HEALTH SOLUTIONS | $0 | – | -388,417 | -100.0% | -0.21% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -6,442 | -100.0% | -0.23% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -55,540 | -100.0% | -0.41% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -58,168 | -100.0% | -0.54% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -169,876 | -100.0% | -0.60% | – |
| DVA | Exit | DAVITA INC | $0 | – | -23,930 | -100.0% | -0.67% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -330,665 | -100.0% | -0.68% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -17,668 | -100.0% | -0.72% | – |
| ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -128,865 | -100.0% | -0.79% | – |
| SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -611,624 | -100.0% | -0.80% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -517,472 | -100.0% | -0.81% | – | |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -76,551 | -100.0% | -1.28% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -136,480 | -100.0% | -1.39% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -158,702 | -100.0% | -1.60% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -44,132 | -100.0% | -2.24% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -133,801 | -100.0% | -2.86% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -238,099 | -100.0% | -3.09% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -167,362 | -100.0% | -3.28% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -54,355 | -100.0% | -3.45% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -272,218 | -100.0% | -3.51% | – |
| AHCO | Exit | ADAPTHEALTH CORP | $0 | – | -399,730 | -100.0% | -3.83% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INCcall | $0 | – | -2,000,000 | -100.0% | -3.97% | – |
| KIDS | Exit | ORTHOPEDIATRICS CORP | $0 | – | -396,162 | -100.0% | -5.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.